TY - JOUR
T1 - An integrated approach to the discovery of potent agelastatin A analogues for brain tumors
T2 - Chemical synthesis and biological, physicochemical and CNS pharmacokinetic analyses
AU - Li, Zhimin
AU - Shigeoka, Daisuke
AU - Caulfield, Thomas R.
AU - Kawachi, Takashi
AU - Qiu, Yushi
AU - Kamon, Takuma
AU - Arai, Masayoshi
AU - Tun, Han W.
AU - Yoshimitsu, Takehiko
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 2013/7
Y1 - 2013/7
N2 - (-)-Agelastatin A (AA), isolated from the coral sea axinellid sponge Agelas dendromorpha, has shown a high antineoplastic activity. We have synthesized eighteen AA analogues and analyzed their cytotoxicities towards three cancer cell lines. By the structure-activity relationship (SAR) study, we identified three novel analogues with higher or comparable cytotoxic activities to AA. They were subjected to chemoinformatic analysis, which revealed physicochemical properties favoring excellent central nervous system (CNS) penetration. CNS pharmacokinetic analysis in murine models validated the chemoinformatic prediction and revealed that these analogues indeed had better CNS penetration than AA. These novel potent AA analogues deserve further evaluation for therapeutic use against cancers, particularly primary and secondary brain tumors.
AB - (-)-Agelastatin A (AA), isolated from the coral sea axinellid sponge Agelas dendromorpha, has shown a high antineoplastic activity. We have synthesized eighteen AA analogues and analyzed their cytotoxicities towards three cancer cell lines. By the structure-activity relationship (SAR) study, we identified three novel analogues with higher or comparable cytotoxic activities to AA. They were subjected to chemoinformatic analysis, which revealed physicochemical properties favoring excellent central nervous system (CNS) penetration. CNS pharmacokinetic analysis in murine models validated the chemoinformatic prediction and revealed that these analogues indeed had better CNS penetration than AA. These novel potent AA analogues deserve further evaluation for therapeutic use against cancers, particularly primary and secondary brain tumors.
UR - http://www.scopus.com/inward/record.url?scp=84879863287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879863287&partnerID=8YFLogxK
U2 - 10.1039/c3md00094j
DO - 10.1039/c3md00094j
M3 - Article
AN - SCOPUS:84879863287
SN - 2040-2503
VL - 4
SP - 1093
EP - 1098
JO - MedChemComm
JF - MedChemComm
IS - 7
ER -